|
Market Closed -
Nasdaq
23:00:00 01/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 1.540 USD | +1.32% |
|
-2.53% | -74.84% |
Evolution of the Average Target: Actuate Therapeutics, Inc.
Evolution of the Target Price: Actuate Therapeutics, Inc.
Changes in Analyst Recommendations: Actuate Therapeutics, Inc.
32fbddd3bb845d7d937fb83.lmEtwsU4Ol7l6B0f9h-5g4Dh4zc0MneoYSiv7uzs3UA._jVY74x6ciaUjVdIolvU4fOvp3kNdjqQKFDJ2LqPswziVHT7nVZ0Kamcfg~dfc6b1caf8a4b65019cd09c139b0b12e
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +658.66% | |||||
| +19.12% | |||||
| +11.09% | |||||
| +64.75% | |||||
| +18.05% | |||||
| +13.05% | |||||
| +6.66% | |||||
| +26.26% | |||||
| -5.63% | |||||
| +25.87% | |||||
| Average | +83.79% | |||||
| Weighted average by Cap. | +19.87% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.540USD
Average target price
11.68USD
Spread / Average Target
+658.66%
High Price Target
15.05USD
Spread / Highest target
+877.27%
Low Price Target
8.000USD
Spread / Lowest Target
+419.48%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- ACTU Stock
- Consensus Actuate Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
